Pure red-cell aplasia: a review

Area of Science:

• Hematology
• Immunology
• Virology

Background:

• Pure red-cell aplasia (PRCA) is a rare anemia defined by the near absence of nucleated red blood cells.
• It presents in congenital and acquired forms, with distinct underlying mechanisms.
• Acquired PRCA is frequently associated with specific viral infections or lymphoid disorders.

Purpose of the Study:

• To elucidate the causes and characteristics of pure red-cell aplasia.
• To understand the etiological factors contributing to both congenital and acquired forms of PRCA.
• To review the clinical course and treatment outcomes for patients with PRCA.

Main Methods:

• Review of existing literature on pure red-cell aplasia.
• Analysis of etiological factors including viral agents (e.g., B19 parvovirus) and underlying diseases.
• Examination of treatment modalities and their efficacy, particularly immunosuppressive therapy.

Main Results:

• Congenital PRCA may result from intrauterine damage to erythroid stem cells.
• Transient acquired PRCA is often caused by B19 parvovirus infection.
• Sustained acquired PRCA is linked to viral infections, immune responses, or toxic damage, frequently in patients with lymphoid diseases.

Conclusions:

• Pure red-cell aplasia has diverse etiologies, ranging from congenital defects to acquired triggers like parvovirus and lymphoid malignancies.
• Treatment with immunosuppressive drugs, especially corticosteroids, can induce remission in many cases.
• Patient outcomes are largely dependent on the management of the primary underlying disorder.